SMTC
872374
Cubic Digital Technology
300344
Marssenger Kitchenware
300894
Hangzhou Onechance Tech Corp.
300792
Hangzhou Hopechart Iot Technology Co., Ltd
688288
CN Stock MarketDetailed Quotes
600267 Zhejiang Hisun Pharmaceutical
- 8.07
- +0.10+1.25%
Market Closed Jan 16 15:00 CST
9.67BMarket Cap-474.71P/E (TTM)
8.17High7.97Low112.90KlotVolume7.98Open7.97Pre Close91.16MTurnover0.94%Turnover RatioLossP/E (Static)1.20BShares9.4752wk High1.18P/B9.67BFloat Cap6.4352wk Low8.77Limit Up1.20BShs Float27.24Historical High7.17Limit Down2.51%Amplitude1.42Historical Low--Dividend TTM8.07Avg Price45.97KlotAsk--Div YieldTTM100Lot Size64.52KlotBid
Zhejiang Hisun Pharmaceutical News
Haizheng Pharmaceutical: Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on obtaining a drug registration certificate
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on obtaining a drug registration certificate
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on changing the limited partner of the investment fund involved in the establishment
Implementation Rules of the Strategy and Sustainable Development Committee of the Board of Directors of Zhejiang Haizheng Pharmaceutical Co., Ltd. (Revised in December 2024)
Zhejiang Haizheng Pharmaceutical Co., Ltd. Accountant Service Selection and Employment System
Announcement of Resolutions of the 34th Meeting of the 9th Board of Directors of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Haizheng Pharmaceutical: Legal Opinion of Shanghai Junlan Law Firm on matters relating to the implementation of the 2021 restricted stock incentive plan repurchase and cancellation of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Haizheng Pharmaceutical: Zhejiang Haizheng Pharmaceutical Co., Ltd. Implementation Notice on Restricted Stock Repurchase and Cancellation of Equity Incentives
Legal Opinion of Shanghai Junlan Law Firm on matters relating to the implementation of the repurchase and cancellation of the 2021 Restricted Stock Incentive Plan of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Zhejiang Haizheng Pharmaceutical Co., Ltd. implementation notice on share incentive restricted stock repurchase and cancellation
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on the company\'s participation in the national centralized procurement of drugs to win the bid
Haizheng Pharmaceutical: Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on its subsidiary obtaining a new veterinary drug registration certificate
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on its subsidiary obtaining a new veterinary drug registration certificate
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on its subsidiary obtaining approval documents for veterinary drug products
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on its subsidiary obtaining approval documents for veterinary drug products
Announcement of Zhejiang Haizheng Pharmaceutical Co., Ltd. on obtaining a drug registration certificate
Zhejiang Haizheng Pharmaceutical Co., Ltd. Minutes of the institutional investor on-site exchange meeting on November 1, 2024
Haizheng Pharmaceutical: Zhejiang Haizheng Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Haizheng Pharmaceutical: Announcement of Resolutions of the 33rd Meeting of the 9th Board of Directors of Zhejiang Haizheng Pharmaceutical Co., Ltd.
Haizheng Pharmaceutical: Announcement of Resolutions of the 19th Meeting of the 9th Board of Supervisors of Zhejiang Haizheng Pharmaceutical Co., Ltd.
